Wikidata

(Q40821569)

English

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

scientific article published on 31 March 2016

In more languages

Statements

title
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
27038238
retrieved
24 September 2017
author name string
Thomas Frisell
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
27038238
retrieved
24 September 2017
Protik Islam-Jakobsson
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
27038238
retrieved
24 September 2017
Jonatan Salzer
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
27038238
retrieved
24 September 2017
Anna Björck
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
27038238
retrieved
24 September 2017
Markus Axelsson
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
27038238
retrieved
24 September 2017
Katharina Fink
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
27038238
retrieved
24 September 2017
Jan Lycke
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
27038238
retrieved
24 September 2017
Fredrik Piehl
series ordinal
12
1 reference
stated in
Europe PubMed Central
PubMed ID
27038238
retrieved
24 September 2017
publication date
31 March 2016
1 reference
stated in
Europe PubMed Central
PubMed ID
27038238
retrieved
24 September 2017
page(s)
950-958
1 reference
stated in
Europe PubMed Central
PubMed ID
27038238
retrieved
24 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40821569&oldid=2086971164"